Studies

Pridopidine EAP2

Neurology Adult Subjects

Protocol PL101-HD501: This is an open-label post-trial expanded access program to provide continued treatment with pridopidine for individuals who completed the PROOF-HD study (PL101-HD301) as well as include treatment naïve HD patients ineligible for clinical trials.

Protocol PL101-ALS501: This EAP will provide access to pridopidine for up to 200 patients with ALS who are ineligible for clinical trials.

HEALEY ALS Platform Trial

Neurology Adult Subjects

The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.